LeonaBio (LONA) Equity Average (2019 - 2026)

LeonaBio (LONA) has 8 years of Equity Average data on file, last reported at $38.5 million in Q1 2026.

• Equity Average for Q1 2026 came in at $38.5 million, down 6.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.5 million (down 6.18% YoY), and the FY2025 annual result was $36.3 million, down 58.5% from the prior year.
• Equity Average rose to $38.5 million in Q1 2026 per LONA's latest filing, from $27.3 million in the prior quarter.
• Over five years, Equity Average peaked at $311.5 million in Q1 2022 and troughed at $27.3 million in Q4 2025.
• A 5-year average of $139.0 million and a median of $118.5 million in 2024 frame the typical range for Equity Average.
• The sharpest annual moves came in 2022 and 2025: Equity Average retreated 2.26% in 2022, then plunged 65.32% in 2025.
• A 5-year view of Equity Average shows it stood at $248.7 million in 2022, then plunged by 42.71% to $142.5 million in 2023, then plunged by 64.06% to $51.2 million in 2024, then tumbled by 46.72% to $27.3 million in 2025, then surged by 41.26% to $38.5 million in 2026.
• Business Quant data shows LONA's Equity Average at $38.5 million in Q1 2026, $27.3 million in Q4 2025, and $29.4 million in Q3 2025.